COMPLETE VACCINE Trademark

Trademark Overview


On Thursday, November 5, 2020, a trademark application was filed for COMPLETE VACCINE with the United States Patent and Trademark Office. The USPTO has given the COMPLETE VACCINE trademark a serial number of 90301302. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 5, 2022. This trademark is owned by Nugenerex Immuno-Oncology. The COMPLETE VACCINE trademark is filed in the Pharmaceutical Products category with the following description:

Human pharmaceutical preparations for the prevention and treatment of viral diseases, autoimmune disorders, inflammatory diseases, cardiovascular diseases, pulmonary diseases, coronary diseases, central nervous system disorders, peripheral neurological system diseases, pain, dermatologic diseases, gastrointestinal diseases, infection-related diseases, metabolic diseases, oncologic diseases, opthalmic diseases, respiratory diseases, cerebrovascular diseases; vaccines; anti-inflammatories; anti-cancer preparations; anti-infectives; and pharmaceutical anti-allergic preparations and substances
complete vaccine

General Information


Serial Number90301302
Word MarkCOMPLETE VACCINE
Filing DateThursday, November 5, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 5, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 7, 2021

Trademark Statements


Goods and ServicesHuman pharmaceutical preparations for the prevention and treatment of viral diseases, autoimmune disorders, inflammatory diseases, cardiovascular diseases, pulmonary diseases, coronary diseases, central nervous system disorders, peripheral neurological system diseases, pain, dermatologic diseases, gastrointestinal diseases, infection-related diseases, metabolic diseases, oncologic diseases, opthalmic diseases, respiratory diseases, cerebrovascular diseases; vaccines; anti-inflammatories; anti-cancer preparations; anti-infectives; and pharmaceutical anti-allergic preparations and substances
Disclaimer with Predetermined Text"VACCINE"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 6, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNugenerex Immuno-Oncology
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMiramar, FL 33025

Party NameNugenerex Immuno-Oncology
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMiramar, FL 33025

Trademark Events


Event DateEvent Description
Tuesday, September 6, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 5, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, February 1, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 7, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 7, 2021PUBLISHED FOR OPPOSITION
Wednesday, November 17, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, November 1, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 26, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 25, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 25, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 23, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 23, 2021NON-FINAL ACTION E-MAILED
Friday, April 23, 2021NON-FINAL ACTION WRITTEN
Monday, April 12, 2021ASSIGNED TO EXAMINER
Wednesday, January 6, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, November 9, 2020NEW APPLICATION ENTERED IN TRAM